Similar articles for PMID: 35165132

Year	Number of Results
2010	2
2011	2
2012	6
2013	4
2014	4
2015	8
2016	10
2017	14
2018	10
2019	18
2020	24
2021	12
2022	7
2023	1
2024	0

1

A practical approach to prescribing antiplatelet therapy in patients with acute coronary syndromes.

Alkhalil M, Kuzemczak M, Bell A, Stern S, Welsford M, Cantor WJ, Goodman SG. Alkhalil M, et al. CMAJ. 2022 Feb 14;194(6):E205-E215. doi: 10.1503/cmaj.202863. CMAJ. 2022. PMID: 35165132 Free PMC article. Review. No abstract available.

2

Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet Therapy?

Cammisotto V, Biondi-Zoccai G, Frati G, Giordano A. Cammisotto V, et al. Am J Cardiovasc Drugs. 2019 Aug;19(4):377-379. doi: 10.1007/s40256-019-00340-w. Am J Cardiovasc Drugs. 2019. PMID: 31030412 No abstract available.

3

The use of antiplatelet agents after an acute coronary syndrome in a large community Italian setting of more than 12 million subjects.

Maggioni AP, Dondi L, Pedrini A, Ronconi G, Calabria S, Cimminiello C, Martini N. Maggioni AP, et al. Eur Heart J Acute Cardiovasc Care. 2019 Sep;8(6):527-535. doi: 10.1177/2048872618801252. Epub 2018 Sep 13. Eur Heart J Acute Cardiovasc Care. 2019. PMID: 30209955

4

Prasugrel in the treatment of acute coronary syndrome.

Spartalis M, Tzatzaki E, Spartalis E, Paschou SA, Athanasiou A, Iliopoulos DC, Siasos G, Voudris V. Spartalis M, et al. Future Cardiol. 2020 Nov;16(6):559-568. doi: 10.2217/fca-2020-0018. Epub 2020 May 11. Future Cardiol. 2020. PMID: 32390477

5

Newer antiplatelet agents in acute coronary syndrome.

Ferro A. Ferro A. BMJ. 2016 Jan 7;352:h7025. doi: 10.1136/bmj.h7025. BMJ. 2016. PMID: 26742542 No abstract available.

6

[The ISAR-REACT 5 trial: is there a winner between prasugrel and ticagrelor in acute coronary syndromes?].

Ferlini M, Galvani M, Visconti LO. Ferlini M, et al. G Ital Cardiol (Rome). 2020 Mar;21(3):171-174. doi: 10.1714/3306.32764. G Ital Cardiol (Rome). 2020. PMID: 32100728 Italian. No abstract available.

7

Antiplatelet therapy in acute coronary syndromes.

Grove EL, Würtz M, Thomas MR, Kristensen SD. Grove EL, et al. Expert Opin Pharmacother. 2015;16(14):2133-47. doi: 10.1517/14656566.2015.1079619. Epub 2015 Aug 17. Expert Opin Pharmacother. 2015. PMID: 26293612 Review.

8

Antiplatelet Therapy in Elderly Patients with Acute Coronary Syndromes: the Clopidogrel Revenge: Possible Reasons for a Bright Comeback.

De Servi S, Landi A, Savonitto S. De Servi S, et al. Cardiovasc Drugs Ther. 2021 Apr;35(2):399-401. doi: 10.1007/s10557-020-07055-0. Epub 2020 Aug 18. Cardiovasc Drugs Ther. 2021. PMID: 32809109 Review. No abstract available.

9

Duration of Dual Antiplatelet Therapy in the Post-Acute Coronary Syndrome Patient.

Bobadilla RV. Bobadilla RV. J Cardiovasc Nurs. 2018 May/Jun;33(3):248-254. doi: 10.1097/JCN.0000000000000452. J Cardiovasc Nurs. 2018. PMID: 29251650 Review.

10

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes.

Schüpke S, Neumann FJ, Menichelli M, Mayer K, Bernlochner I, Wöhrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Flügel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, Möllmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Schühlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, Tölg R, Trenk D, Schunkert H, Laugwitz KL, Kastrati A; ISAR-REACT 5 Trial Investigators. Schüpke S, et al. N Engl J Med. 2019 Oct 17;381(16):1524-1534. doi: 10.1056/NEJMoa1908973. Epub 2019 Sep 1. N Engl J Med. 2019. PMID: 31475799 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year